|
시장보고서
상품코드
1741411
구조 흡입기 시장 : 제품 유형별, 적응증별, 환자 유형별, 투약형별, 최종 사용자별, 지역별Rescue Inhaler Market, By Product Type, By Indication, By Patient Type, By Dosage Form, By End User, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
구조 흡입기 시장은 2025년에는 199억 5,000만 달러로 추정되고, 2032년에는 360억 달러에 이를 전망이며, 2025-2032년 CAGR 8.8%로 성장이 예측되고 있습니다.
| 보고 범위 | 보고서 세부정보 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 199억 5,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 CAGR(2025-2032년) : | 8.80% | 예측 금액(2032년) | 360억 달러 |
구조 흡입기는 릴리버 흡입기로도 알려져 있으며 천식과 만성 폐색성 폐질환(COPD) 등의 호흡기 질환을 가진 사람이 일반적으로 사용하는 약물 장치입니다. 천식 발작 및 호흡 곤란 시 기도를 넓히는 즉효성 기관지 확장약이 포함되어 있습니다. 이 약은 천명, 숨이 차거나 가슴이 답답해지는 등의 증상을 빠르게 완화합니다. 구조 흡입기는 신속한 완화를 초래하지만 증상의 근본적인 원인을 치료하는 것은 아닙니다. 급성 호흡기 증상을 관리하고 환자의 삶의 질을 향상시키기 위해 필수적인 도구입니다.
시장 역학 :
호흡기 질환의 유병률 증가, 노년 인구 증가, 의료 지출 증가는 예측 기간에 걸쳐 세계 구조 흡입기 시장의 성장을 가속할 것으로 예측됩니다. 또한 기술의 진보도 예측 기간 동안 세계 구조 흡입기 시장의 성장을 뒷받침할 것으로 예상됩니다. 신흥국 시장에서의 높은 성장 잠재력, 재가 케어 환경 수요 확대, 천식용 생물제제 개발, 호흡기 케어를 위한 원격 의료에 대한 관심 고조는 예측 기간 동안 세계의 구조 흡입기 시장에 성장 기회를 가져올 것으로 예상됩니다.
그러나 엄격한 규제 요건, 흡입기 부작용 및 흡입기의 높은 비용은 예측 기간 동안 구조 흡입기 시장의 성장을 방해할 것으로 예측됩니다.
이 조사의 주요 특징
- 본 보고서는 구조 흡입기 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측 기간(2025-2032년) 시장 규모 및 복합연간 성장률(CAGR%)을 제공합니다.
- 다른 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 구조 흡입기 시장의 주요 기업 프로파일을 제공합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자 및 기업 경영진이 미래의 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 할 수 있게 합니다.
- 구조 흡입기 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자를 지원합니다.
- 이해관계자는 구조 흡입기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적 및 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의 및 범위
- 주요 요약
- 일관된 기회 지도(COM)
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 호흡기 질환 유병률 상승
- 고령화 인구 증가
- 제품 승인 향상
- 성장 억제요인
- 엄격한 규제 요건
- 제품 리콜
- 흡입기의 고비용
- 기회
- 호흡기 케어에 있어서 원격 의료에 대한 주목 고조
- 천식에 대한 생물학적 제제 개발
- 신흥 시장에서 높은 성장 가능성
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시 및 승인
- PEST 분석
- Porter's Five Forces 분석
- 합병 및 인수 시나리오
제4장 구조 흡입기 시장 : 코로나 바이러스(COVID-19) 유행의 영향
- COVID-19 역학
- 공급측 및 수요측 분석
- 경제에 미치는 영향
제5장 구조 흡입기 시장 : 제품 유형별(2020-2032년)
- 정량 분무식 흡입기
- 드라이 파우더 흡입기
- 분무기
- 소프트 미스트 흡입기
- 기타
제6장 구조 흡입기 시장 : 적응증별(2020-2032년)
- 천식
- COPD
- 알레르기성 비염
- 폐동맥고혈압
- 기타
제7장 구조 흡입기 시장 : 환자 유형별(2020-2032년)
- 성인
- 소아
제8장 구조 흡입기 시장 : 제형별(2020-2032년)
- 캡슐
- 액체
- 서스펜션
- 기타
제9장 구조 흡입기 시장 : 최종 사용자별(2020-2032년)
- 재택치료
- 병원 및 진료소
제10장 구조 흡입기 시장 : 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 북아프리카
- 남아프리카
- 중앙 아프리카
제11장 경쟁 구도
- GSK plc.
- Teva Pharmaceutical Industries Ltd.
- Cipla Inc.
- PARI Pharma GmbH
- Lupin
- AstraZeneca
- Boehringer Ingelheim International GmbH.
- Novartis
- Pfizer
- Sunovion Pharmaceuticals
- 3M
- OMRON Healthcare Co., Ltd.
- Koninklijke Philips NV
- Invacare
- Schiller
- Teleflex Incorporated
제12장 섹션
- 조사 방법
- 출판사에 대해
Rescue Inhaler Market is estimated to be valued at USD 19.95 Bn in 2025 and is expected to reach USD 36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 19.95 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.80% | 2032 Value Projection: | USD 36 Bn |
A rescue inhaler, also known as a reliever inhaler, is a medication device commonly used by individuals with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). It contains a fast-acting bronchodilator medication that helps open up airways during an asthma attack or breathing difficulties. This medication quickly eases symptoms like wheezing, shortness of breath, and chest tightness. Rescue inhalers offer rapid relief, but they do not treat the underlying cause of the condition. They are an essential tool for managing acute respiratory symptoms and improving the patient's quality of life.
Market Dynamics:
Rising prevalence of respiratory diseases, increasing geriatric population, and rising healthcare expenditure are anticipated to drive growth of the global rescue inhaler market over the forecast period. Moreover, technological advancements is also expected to boost the growth of the global rescue inhaler market over the forecast period. High growth potential in emerging markets, growing demand for home care settings, development of biologics for asthma, rising focus on telehealth for respiratory care are expected to create growth opportunities for the global rescue inhaler market during the forecast period.
However, stringent regulatory requirements, side effects of inhalers, and high cost of inhalers are expected to hamper growth of the rescue inhaler market over the forecast period.
Key features of the study:
- This report provides an in-depth analysis of the rescue inhaler market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the rescue inhaler market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include GSK plc., Teva Pharmaceutical Industries Ltd., Cipla Inc., PARI Pharma GmbH, Lupin, AstraZeneca, Boehringer Ingelheim International GmbH., Novartis, Pfizer, Sunovion Pharmaceuticals, 3M, OMRON Healthcare Co., Ltd., Koninklijke Philips N.V., Schiller, and Teleflex Incorporated
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The rescue inhaler market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the rescue inhaler market
Rescue Inhaler Market Detailed Segmentation:
- By Product Type:
- Metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Soft Mist Inhalers
- Others
- By Indication:
- Asthma
- COPD
- Allergic Rhinitis
- Pulmonary Arterial Hypertension
- Others
- By Patient Type:
- Adult
- Pediatric
- By Dosage Form:
- Capsules
- Solution
- Suspension
- Others
- By End User:
- Home Care Settings
- Hospitals & Clinics
- By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profile:
- GSK plc.
- Teva Pharmaceutical Industries Ltd.
- Cipla Inc.
- PARI Pharma GmbH
- Lupin
- AstraZeneca
- Boehringer Ingelheim International GmbH.
- Novartis
- Pfizer
- Sunovion Pharmaceuticals
- 3M
- Omron Healthcare
- Koninklijke Philips N.V.
- Invacare
- Schiller
- Teleflex Incorporated
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Indication
- Market Snippet, By Patient Type
- Market Snippet, By Dosage Form
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rising prevalence of respiratory diseases
- Increasing geriatric population
- Increasing Product Approval
- Restraints
- Stringent regulatory requirements
- Product Recall
- High cost of inhalers
- Opportunities
- Rising focus on telehealth for respiratory care
- Development of biologics for asthma
- High growth potential in emerging markets
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Rescue Inhaler Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Rescue Inhaler Market, By Product Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Metered Dose Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Dry Powder Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Nebulizers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Soft Mist Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
6. Rescue Inhalers Market, By Indication, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- COPD
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Pulmonary Arterial Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
7. Rescue Inhalers Market, By Patient Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
8. Rescue Inhalers Market, By Dosage Form, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Suspension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
9. Rescue Inhalers Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
10. Rescue Inhalers Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
- North Africa
- South Africa
- Central Africa
11. Competitive Landscape
- GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PARI Pharma GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lupin
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sunovion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- 3M
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- OMRON Healthcare Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Invacare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Schiller
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teleflex Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
샘플 요청 목록